Metabolic Syndrome and Long-Term Cardiovascular Outcomes in NSTEMI With Unstable Angina

Study Questions:

What is the impact of metabolic syndrome (MS) on long-term clinical outcomes in patients with pure non−ST-segment elevation myocardial infarction (NSTEMI) or unstable angina pectoris (USAP)?